Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc RNS Release

Holding(s) in Company

RNS Number : 5174Y
Redx Pharma plc
03 March 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Redx Pharma plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):


 

3. Full name of person(s) subject to the notification obligation:

 

 

Lanstead Capital LP

4. Full name of shareholder(s)

(if different from 3.):


5. Date of the transaction and date on which the threshold is crossed or reached:

 

1 March 2017

6. Date on which issuer notified:

3 March 2017

7. Threshold(s) that is/are crossed or reached:

 

3%, 4%, 5%, 6%, 7%, 8%, 9%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

 

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00BSNB6S51

0

0

12,075,000

12,075,000


9.55%



 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial

instrument

Exercise

price

Expiration

date

Exercise/

Conversion period

instrument refers to

% of voting rights

 

N/A





Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

12,075,000

9.55%

 

9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable:

N/A


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease to hold:


12. Date on which proxy holder will cease to hold voting rights:



13. Additional information:


14. Contact name:

Lisa De Vargas, Lanstead Partners Limited

15. Contact telephone number:

+1 (801) 895-3700

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBSGDXDXGBGRX



Redx Pharma Plc Timeline

CN Research
April 06 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use